SCHEMBL1702324

SCHEMBL1702324

CCC(=O)OC(=O)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28829170 0.97 ALDH1A1 (0.43)
SCHEMBL288431 0.87
Hydrogen Peroxide SCHEMBL4370693 0.84 GLRA1 (0.50)
SCHEMBL6753492 0.84 GLRA1 (0.41)
SCHEMBL10794891 0.84 GLRA1 (0.41)
Hydrochloric Acid SCHEMBL27360124 0.84 GLRA1 (0.41)
SCHEMBL6258848 0.84 GLRA1 (0.41)
SCHEMBL9276 0.84
Acetic Acid SCHEMBL28075723 0.82 GLRA1 (0.42)
Butanedione SCHEMBL28120733 0.82 TSHR (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114341351-A Strains and methods for producing hemoprotein 非凡食品有限公司 2022-04-12 CN claimed
EP-0845505-B1 Spherical colour pigments, process for their preparation and their use DMC2 DEGUSSA METALS CATALYSTS (DE) 2001-10-04 EP claimed
US-4874752-A INHIBIT COLLAGEN BIOSYNTHESIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1989-10-17 US claimed
US-12551461-B2 Compositions of triglycerides and uses thereof ULTRAGENYX PHARMACEUTICAL INC. (US) 2026-02-17 US disclosed
EP-3247328-B1 METHODS, COMPOSITIONS, AND SYSTEMS FOR DELIVERING THERAPEUTIC AND DIAGNOSTIC AGENTS INTO CELLS GENEVANT SCIENCES GMBH (CH) 2026-01-07 EP disclosed
WO-2025184781-A1 METABOLIC MARKER COMBINATION AND USE THEREOF IN EVALUATION OF ARTERIOSCLEROSIS GRADE 深圳华大基因股份有限公司 2025-09-12 WO disclosed
US-20250186599-A1 BLOCK COPOLYMERS GENEVANT SCIENCES GMBH (CH) 2025-06-12 US disclosed
US-20250120936-A1 COMPOSITIONS OF TRIGLYCERIDES AND USES THEREOF ULTRAGENYX PHARMACEUTICAL INC. 2025-04-17 US disclosed
US-20250120935-A1 COMPOSITIONS OF TRIGLYCERIDES AND USES THEREOF ULTRAGENYX PHARMACEUTICAL INC. 2025-04-17 US disclosed
US-20250120934-A1 COMPOSITIONS OF TRIGLYCERIDES AND USES THEREOF ULTRAGENYX PHARMACEUTICAL INC. 2025-04-17 US disclosed
WO-2025041353-A1 BODY FLUID ANALYSIS METHOD AND SYSTEM 株式会社日立ハイテクソリューションズ 2025-02-27 WO disclosed
US-7544662-B2 Polypeptides useful for appetite suppression CARLE DEVELOPMENT FOUNDATION (US) 2009-06-09 US disclosed
US-20060276401-A1 Polypeptides useful for appetite suppression NELSON RALPH A 2006-12-07 US disclosed
US-20060204589-A1 Bear derived isolate and method NELSON RALPH A 2006-09-14 US disclosed
US-7060300-B2 Bear derived isolate and method CARLE DEVELOPMENT FOUNDATION (US) 2006-06-13 US disclosed
US-6855337-B1 Bear derived isolate and method CARLE DEVELOPMENT FOUNDATION (US) 2005-02-15 US disclosed
CN-1029325-C Oil pipe with nickel-phosphorus alloy anti-corrosion coating and its producing method SUN KENING (CN) 1995-07-12 CN disclosed
CN-1089341-A Oil pipe and manufacture method with nickel-phosphorus alloy anti-corrosion coating SUN KENING (CN) 1994-07-13 CN disclosed
EP-0095229-A2 Acetaminophen analogs, antigens, and antibodies SYVA COMPANY (US) 1983-11-30 EP disclosed
EP-0082088-A1 Derivatives of amino acids and their therapeutic use Roques, Bernard (FR) 1983-06-22 EP disclosed